ANIP

ANI PHARMACEUTICALS INC

Sales chart range
Log in to watch ANIP
Latest sale
$385k
Nov 18 · Routine
Form 4 sales
185
On record
Form 144 notices
34
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

7
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleRoutine
    Aug 13 2026

    Sold 500 shares at $75.48 ($38k)

    Cook Meredith, SR. VP, GENERAL COUNSEL & SEC.

    10b5-1 planSold 0.7% of holdings ($5.7M position)74,424 shares left1.3x usual sizeFiling

  2. 2 Form 4 saleRoutine
    Aug 25 +12 days

    Sold 5,400 shares at $74.30 ($401k)

    Lalwani Nikhil, PRESIDENT & CEO

    10b5-1 planSold 1.5% of holdings ($26M position)344,489 shares left0.1x usual sizeFiling

  3. 3 Form 4 saleRoutine
    Aug 31 +6 days

    Sold 2,850 shares at $72.80 ($207k)

    Carey Stephen P., SVP & CFO

    10b5-1 planSold 1.6% of holdings ($12.7M position)171,843 shares left0.9x usual sizeFiling

  4. 4 Form 4 saleRoutine
    Sep 11 +11 days

    Sold 1,000 shares at $71.53 ($72k)

    Thoma Jeanne, Director

    10b5-1 planSold 3.6% of holdings ($2M position)26,762 shares leftFiling

  5. 5 Form 4 saleRoutine
    Sep 14 +3 days

    Sold 500 shares at $70.79 ($35k)

    Cook Meredith, SR. VP, GENERAL COUNSEL & SEC.

    10b5-1 planSold 0.7% of holdings ($5.3M position)73,924 shares left1.3x usual sizeFiling

  6. 6 Form 4 saleRoutine
    Sep 15 +1 day

    Sold 5,400 shares at $71.00 ($383k)

    Lalwani Nikhil, PRESIDENT & CEO

    10b5-1 planSold 1.6% of holdings ($24.5M position)339,089 shares left0.1x usual sizeFiling

  7. 7 Form 4 saleRoutine
    Sep 29 +14 days

    Sold 2,850 shares at $73.00 ($208k)

    Carey Stephen P., SVP & CFO

    10b5-1 planSold 1.7% of holdings ($12.5M position)168,993 shares left0.9x usual sizeFiling

  8. 8 Form 4 saleRoutine
    Nov 18 +50 days

    Sold 5,400 shares at $71.22 ($385k)

    Lalwani Nikhil, PRESIDENT & CEO

    10b5-1 planSold 1.6% of holdings ($23.8M position)328,289 shares left0.2x usual sizeFiling

Every transaction

Loading transactions…

Sales, notices and lockups (219)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for ANIP
Source
Nov 18, 2026Lalwani NikhilPRESIDENT & CEOForm 4 sale5,400$385k1.6%RoutineSEC
Sep 29, 2026Carey Stephen P.SVP & CFOForm 4 sale2,850$208k1.7%RoutineSEC
Sep 15, 2026Lalwani NikhilPRESIDENT & CEOForm 4 sale5,400$383k1.6%RoutineSEC
Sep 14, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale500$35k0.7%RoutineSEC
Sep 11, 2026Thoma JeanneDirectorForm 4 sale1,000$72k3.6%RoutineSEC
Aug 31, 2026Carey Stephen P.SVP & CFOForm 4 sale2,850$207k1.6%RoutineSEC
Aug 25, 2026Lalwani NikhilPRESIDENT & CEOForm 4 sale5,400$401k1.5%RoutineSEC
Aug 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale500$38k0.7%RoutineSEC
Aug 10, 2026Gutwerg OriSVP, GENERICSForm 4 sale3,162$243k4.0%No planSEC
Jul 29, 2026Carey Stephen P.SVP & CFOForm 4 sale2,850$232k1.6%RoutineSEC
Jul 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale500$41k0.6%RoutineSEC
Jul 2, 2026Carey Stephen P.SVP & CFOForm 4 sale3,313$285k1.8%RoutineSEC
Jun 29, 2026Carey Stephen P.SVP & CFOForm 4 sale2,850$240k1.6%RoutineSEC
Jun 12, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale500$41k0.6%RoutineSEC
Jun 8, 2026Haughey ThomasDirectorForm 4 sale2,000$162k4.9%RoutineSEC
Jun 5, 2026Carey Stephen P.SVP & CFOForm 4 sale3,312$265k1.8%RoutineSEC
May 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale500$39k0.6%RoutineSEC
May 13, 2026Walsh Patrick DDirectorForm 4 sale13,973$1.1M26.7%UnusualSEC
May 12, 2026Gutwerg OriSVP, GENERICSForm 4 sale2,772$220k3.4%No planSEC
May 12, 2026Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDSForm 4 sale459$36k1.2%No planSEC
May 11, 2026Lalwani NikhilPRESIDENT & CEOForm 4 sale55,000$4.3M13.6%No planSEC
Apr 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale500$39k0.6%RoutineSEC
Mar 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale500$36k0.6%RoutineSEC
Mar 13, 2026Mutz ChristopherHEAD OF RARE DISEASEForm 4 sale3,162$227k3.3%RoutineSEC
Mar 11, 2026Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDSForm 4 sale4,772$357k11.0%No planSEC
Mar 9, 2026Davis KristaSVP, CHIEF HR OFFICERForm 4 sale6,572$488k11.2%UnusualSEC
Mar 9, 2026Mutz ChristopherHEAD OF RARE DISEASEForm 4 sale5,723$425k5.7%RoutineSEC
Mar 5, 2026Carey Stephen P.SVP & CFOForm 4 sale7,312$552k3.8%No planSEC
Mar 3, 2026Gutwerg OriSVP, GENERICSForm 4 sale2,060$158k2.4%No planSEC
Mar 3, 2026Walsh Patrick DDirectorForm 4 sale6,000$445k10.3%No planSEC
Mar 2, 2026Mutz ChristopherHEAD OF RARE DISEASEForm 4 sale417$31k0.4%RoutineSEC
Feb 20, 2026Davis KristaSVP, CHIEF HR OFFICERForm 4 sale3,814$296k7.2%UnusualSEC
Feb 20, 2026Mutz ChristopherHEAD OF RARE DISEASEForm 4 sale5,323$415k5.9%RoutineSEC
Feb 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale500$38k0.7%RoutineSEC
Feb 12, 2026Mutz ChristopherHEAD OF RARE DISEASEForm 4 sale7,032$538k7.1%RoutineSEC
Jan 13, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale500$42k0.7%RoutineSEC
Dec 18, 2025Davis KristaSVP, CHIEF HR OFFICERForm 4 sale1,622$134k2.7%RoutineSEC
Dec 12, 2025Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale400$33k0.5%RoutineSEC
Dec 5, 2025Tannenbaum Renee PDirectorForm 4 sale1,800$146k6.7%No planSEC
Nov 13, 2025Walsh Patrick DDirectorForm 4 sale8,643$751k12.3%No planSEC
Nov 13, 2025Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale400$35k0.5%RoutineSEC
Nov 13, 2025Gassert ChadSVP - CORP. DEV. & STRATEGYForm 4 sale14,736$1.3M8.5%No planSEC
Oct 13, 2025Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale400$36k0.5%RoutineSEC
Sep 19, 2025Davis KristaSVP, CHIEF HR OFFICERForm 4 sale1,000$98k1.6%RoutineSEC
Sep 12, 2025Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale400$39k0.5%RoutineSEC
Sep 3, 2025Pera Antonio RDirectorForm 4 sale7,292$692k24.3%No planSEC
Aug 25, 2025Leonard Matthew JDirectorForm 4 sale2,528$229k26.9%UnusualSEC
Aug 22, 2025Davis KristaSVP, CHIEF HR OFFICERForm 4 sale1,763$161k2.7%No planSEC
Aug 21, 2025Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale100,000$9M18.8%UnusualSEC
Aug 20, 2025Pera Antonio RDirectorForm 4 sale5,421$486k15.3%No planSEC
Aug 18, 2025Thoma JeanneDirectorForm 4 sale21,540$1.9M47.9%UnusualSEC
Aug 18, 2025Leonard Matthew JDirectorForm 4 sale6,937$612k42.5%UnusualSEC
Aug 15, 2025Gassert ChadSVP - CORP. DEV. & STRATEGYForm 4 sale20,000$1.7M10.4%No planSEC
Aug 15, 2025Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale100,000$8.8M15.8%UnusualSEC
Aug 15, 2025Walsh Patrick DDirectorForm 4 sale9,000$801k11.4%No planSEC
Aug 13, 2025Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale400$36k0.5%RoutineSEC
Aug 12, 2025Gutwerg OriSVP, GENERICSForm 4 sale5,873$508k6.5%No planSEC
Aug 12, 2025Lalwani NikhilPRESIDENT & CEOForm 4 sale56,960$4.9M12.2%No planSEC
Aug 12, 2025Carey Stephen P.SVP & CFOForm 4 sale50,000$4.3M21.7%UnusualSEC
Aug 12, 2025Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDSForm 4 sale4,975$426k10.9%No planSEC
Aug 12, 2025Haughey ThomasDirectorForm 4 sale19,341$1.7M34.6%UnusualSEC
Jul 14, 2025Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale400$26k0.5%RoutineSEC
Jun 13, 2025Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale400$25k0.5%RoutineSEC
May 15, 2025Gutwerg OriSVP, GENERICSForm 4 sale881$53k1.0%No planSEC
May 14, 2025Mutz ChristopherHEAD OF RARE DISEASEForm 4 sale4,000$242k3.6%No planSEC
May 13, 2025Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale400$25k0.5%RoutineSEC
May 9, 2025Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale700$54k0.1%RoutineSEC
Apr 14, 2025Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale400$28k0.5%RoutineSEC
Mar 19, 2025Davis KristaSVP, CHIEF HR OFFICERForm 4 sale1,866$121k2.8%RoutineSEC
Mar 13, 2025Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale400$25k0.5%RoutineSEC
Mar 7, 2025Davis KristaSVP, CHIEF HR OFFICERForm 4 sale1,000$61k1.5%RoutineSEC
Mar 5, 2025Gutwerg OriSVP, GENERICSForm 4 sale5,384$323k5.4%No planSEC
Feb 21, 2025Davis KristaSVP, CHIEF HR OFFICERForm 4 sale1,000$60k1.4%RoutineSEC
Feb 13, 2025Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale400$24k0.5%RoutineSEC
Jan 13, 2025Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale400$22k0.7%RoutineSEC
Dec 17, 2024Carey Stephen P.SVP & CFOForm 4 sale7,500$418k4.6%No planSEC
Dec 17, 2024Carey Stephen P.OfficerForm 144 notice7,500$414kNoticeSEC
Dec 13, 2024Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$14k0.4%RoutineSEC
Dec 11, 2024Davis KristaSVP, CHIEF HR OFFICERForm 4 sale1,000$60k2.0%RoutineSEC
Nov 26, 2024Lalwani NikhilPRESIDENT & CEOForm 4 sale33,481$1.9M8.3%No planSEC
Nov 26, 2024Lalwani NikhilOfficerForm 144 notice33,481$1.9MNoticeSEC
Nov 15, 2024Mutz ChristopherHEAD OF RARE DISEASEForm 4 sale6,500$375k7.8%No planSEC
Nov 13, 2024Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$15k0.4%RoutineSEC
Oct 14, 2024Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$14k0.4%RoutineSEC
Sep 13, 2024Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$14k0.4%RoutineSEC
Aug 13, 2024Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$15k0.4%RoutineSEC
Jul 18, 2024Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale2,743$170k0.4%RoutineSEC
Jul 17, 2024Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale47,257$3M6.9%RoutineSEC
Jul 12, 2024Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$16k0.4%RoutineSEC
Jul 1, 2024Gassert ChadSVP - CORP. DEV. & STRATEGYForm 4 sale20,000$1.3M9.4%RoutineSEC
Jun 21, 2024Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale20,000$1.2M2.8%RoutineSEC
Jun 20, 2024Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale30,000$1.8M4.1%RoutineSEC
Jun 13, 2024Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$16k0.4%RoutineSEC
Jun 5, 2024Gutwerg OriSVP, GENERICSForm 4 sale2,985$200k3.7%No planSEC
Jun 4, 2024Carey Stephen P.SVP & CFOForm 4 sale5,000$318k3.0%No planSEC
Jun 3, 2024Gassert ChadSVP - CORP. DEV. & STRATEGYForm 4 sale20,000$1.3M8.6%RoutineSEC
May 21, 2024Mutz ChristopherHEAD OF RARE DISEASEForm 4 sale2,000$123k2.3%No planSEC
May 20, 2024Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale12,855$795k1.7%RoutineSEC
May 17, 2024Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale37,145$2.4M4.7%RoutineSEC
May 16, 2024Tannenbaum Renee PDirectorForm 4 sale2,000$128k9.9%No planSEC
May 14, 2024Lalwani NikhilPRESIDENT & CEOForm 4 sale16,669$1.1M4.2%No planSEC
May 13, 2024Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$17k0.4%RoutineSEC
May 1, 2024Gassert ChadSVP - CORP. DEV. & STRATEGYForm 4 sale20,000$1.3M7.9%RoutineSEC
Apr 19, 2024Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale27,232$1.8M3.4%RoutineSEC
Apr 17, 2024Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale22,768$1.5M2.7%RoutineSEC
Apr 12, 2024Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$17k0.4%RoutineSEC
Apr 1, 2024Gassert ChadSVP - CORP. DEV. & STRATEGYForm 4 sale20,000$1.3M7.3%RoutineSEC
Mar 13, 2024Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$17k0.4%RoutineSEC
Mar 11, 2024Gassert ChadSVP - CORP. DEV. & STRATEGYForm 4 sale20,000$1.3M6.8%RoutineSEC
Mar 11, 2024Carey Stephen P.SVP & CFOForm 4 sale7,787$510k4.2%No planSEC
Mar 8, 2024Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale10,000$672k1.2%RoutineSEC
Mar 8, 2024Lalwani NikhilPRESIDENT & CEOForm 4 sale45,257$3M9.9%No planSEC
Mar 7, 2024Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale40,000$2.6M4.5%RoutineSEC
Mar 7, 2024Marken James G.SVP OPS & PROD DEVForm 4 sale24,338$1.6M16.4%No planSEC
Mar 5, 2024Mutz ChristopherHEAD OF RARE DISEASEForm 4 sale5,000$330k5.4%No planSEC
Mar 4, 2024Pera Antonio RDirectorForm 4 sale7,000$456k20.8%No planSEC
Feb 13, 2024Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$14k0.7%RoutineSEC
Jan 23, 2024Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale25,216$1.4M2.8%RoutineSEC
Jan 18, 2024Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale24,784$1.4M2.7%RoutineSEC
Jan 12, 2024Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$14k0.7%RoutineSEC
Dec 19, 2023Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale50,000$2.6M5.1%RoutineSEC
Dec 11, 2023Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$12k0.7%RoutineSEC
Nov 17, 2023Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale13,000$663k1.3%RoutineSEC
Nov 17, 2023Shanmugam MuthusamyOfficerForm 144 notice13,000$663kNoticeSEC
Nov 16, 2023Shanmugam MuthusamyOfficerForm 144 notice6,448$333kNoticeSEC
Nov 16, 2023Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale36,190$1.9M3.5%RoutineSEC
Nov 15, 2023Davis KristaSVP, CHIEF HR OFFICERForm 4 sale2,622$141k7.4%No planSEC
Nov 15, 2023Shanmugam MuthusamyOfficerForm 144 notice7,647$410kNoticeSEC
Nov 14, 2023Shanmugam MuthusamyOfficerForm 144 notice22,905$1.2MNoticeSEC
Nov 13, 2023Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Form 4 sale250$13k0.7%RoutineSEC
Nov 10, 2023Mutz ChristopherHEAD OF RARE DISEASEForm 4 sale3,000$157k4.5%No planSEC
Oct 19, 2023Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale25,000$1.4M2.4%RoutineSEC
Oct 19, 2023Shanmugam MuthusamyOfficerForm 144 notice10,000$571kNoticeSEC
Oct 18, 2023Shanmugam MuthusamyOfficerForm 144 notice6,242$361kNoticeSEC
Oct 17, 2023Shanmugam MuthusamyOfficerForm 144 notice8,758$513kNoticeSEC
Oct 16, 2023Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale25,000$1.4M2.3%RoutineSEC
Oct 16, 2023Shanmugam MuthusamyOfficerForm 144 notice13,063$762kNoticeSEC
Oct 13, 2023Shanmugam MuthusamyOfficerForm 144 notice11,937$687kNoticeSEC
Oct 2, 2023Gassert ChadSVP - CORP. DEV. & STRATEGYForm 4 sale20,000$1.1M6.4%RoutineSEC
Sep 19, 2023Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale50,000$3.1M4.4%RoutineSEC
Sep 19, 2023Shanmugam MuthusamyOfficerForm 144 notice25,333$1.6MNoticeSEC
Sep 18, 2023Shanmugam MuthusamyOfficerForm 144 notice8,425$519kNoticeSEC
Sep 15, 2023Shanmugam MuthusamyOfficerForm 144 notice16,242$1MNoticeSEC
Sep 1, 2023Gassert ChadSVP - CORP. DEV. & STRATEGYForm 4 sale20,000$1.3M6.0%RoutineSEC
Aug 29, 2023Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale50,000$3.2M4.2%No planSEC
Aug 29, 2023Shanmugam MuthusamyOfficerForm 144 notice25,000$1.6MNoticeSEC
Aug 28, 2023Shanmugam MuthusamyOfficerForm 144 notice25,000$1.6MNoticeSEC
Aug 23, 2023Gutwerg OriSVP, GENERICSForm 4 sale15,561$971k20.3%No planSEC
Aug 23, 2023Marken James G.SVP OPS & PROD DEVForm 4 sale3,932$248k2.9%No planSEC
Aug 18, 2023Brown Robert E. JRObserver for Board of DirectorsForm 144 notice15,977$952kNoticeSEC
Aug 16, 2023Meridian Venture Partners II LP10% ownerForm 4 sale200,000$11.7M9.9%No planSEC
Aug 16, 2023Meridian Venture Partners II LP10% StockholderForm 144 notice200,000$11.7MNoticeSEC
Aug 15, 2023Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale50,000$3.1M4.1%RoutineSEC
Aug 15, 2023Shanmugam MuthusamyOfficerForm 144 notice22,110$1.4MNoticeSEC
Aug 15, 2023Lalwani NikhilPresident, CEOForm 144 notice11,616$708kNoticeSEC
Aug 15, 2023Lalwani NikhilPRESIDENT & CEOForm 4 sale68,282$4M16.2%No planSEC
Aug 14, 2023Carey Stephen P.SVP & CFOForm 4 sale17,639$1.1M10.2%No planSEC
Aug 14, 2023Pera Antonio RDirectorForm 4 sale3,000$181k8.2%RoutineSEC
Aug 14, 2023Carey Stephen P.OfficerForm 144 notice17,639$1.1MNoticeSEC
Aug 14, 2023Shanmugam MuthusamyOfficerForm 144 notice27,890$1.7MNoticeSEC
Aug 14, 2023Pera Antonio RDirectorForm 144 notice3,000$181kNoticeSEC
Aug 11, 2023Lalwani NikhilPresident, CEOForm 144 notice56,666$3.4MNoticeSEC
Aug 1, 2023Gassert ChadSVP - CORP. DEV. & STRATEGYForm 4 sale20,000$1M5.7%RoutineSEC
Jul 21, 2023Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale23,469$1.2M1.9%RoutineSEC
Jul 21, 2023Shanmugam MuthusamyOfficerForm 144 notice11,500$604kNoticeSEC
Jul 20, 2023Shanmugam MuthusamyOfficerForm 144 notice6,000$309kNoticeSEC
Jul 19, 2023Shanmugam MuthusamyOfficerForm 144 notice5,969$307kNoticeSEC
Jul 18, 2023Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale26,531$1.4M2.1%RoutineSEC
Jul 18, 2023Shanmugam MuthusamyOfficerForm 144 notice6,700$347kNoticeSEC
Jul 17, 2023Shanmugam MuthusamyOfficerForm 144 notice9,831$502kNoticeSEC
Jul 14, 2023Shanmugam MuthusamyOfficerForm 144 notice10,000$504kNoticeSEC
Jul 3, 2023Gassert ChadSVP - CORP. DEV. & STRATEGYForm 4 sale20,000$1.1M5.4%RoutineSEC
Jun 23, 2023Shanmugam MuthusamyOfficerForm 144 notice10,000$515kNoticeSEC
Jun 22, 2023Gassert ChadSVP - CORP. DEV. & STRATEGYForm 4 sale20,000$1M5.1%RoutineSEC
Jun 22, 2023Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSForm 4 sale40,000$2.1M84.4%RoutineSEC
Jun 22, 2023Shanmugam MuthusamyOfficerForm 144 notice13,500$694kNoticeSEC
Jun 21, 2023Shanmugam MuthusamyOfficerForm 144 notice11,843$616kNoticeSEC
Jun 20, 2023Shanmugam MuthusamyOfficerForm 144 notice14,657$761kNoticeSEC
Dec 1, 2022Meridian Venture Partners II GP, L.P.10% ownerForm 4 sale200,000$7.7M9.0%Plan not statedSEC
Aug 15, 2022Marken James G.SVP OPS & PROD DEVForm 4 sale18,066$673k13.3%Plan not statedSEC
Aug 20, 2019Brown Robert E. JRDirectorForm 4 sale7,579$517k0.3%Plan not statedSEC
Aug 16, 2019Brown Robert E. JRDirectorForm 4 sale62,024$4.3M2.7%Plan not statedSEC
Aug 13, 2019Meridian Venture Partners II LP10% ownerForm 4 sale61,697$4.4M2.6%Plan not statedSEC
May 17, 2019Marken James G.SVP Ops & Prod DevForm 4 sale8,907$629k12.7%Plan not statedSEC
May 15, 2019Przybyl ArthurPresident and CEOForm 4 sale30,000$2.1M12.9%Plan not statedSEC
May 14, 2019Marken James G.SVP Ops & Prod DevForm 4 sale4,917$346k6.6%Plan not statedSEC
May 13, 2019Schrepfer Robert WSVP - New Bus Dev & Spec SalesForm 4 sale2,409$171k4.1%Plan not statedSEC
Mar 19, 2019Przybyl ArthurPresident and CEOForm 4 sale27,625$1.8M11.9%Plan not statedSEC
Mar 13, 2019Schrepfer Robert WSVP - New Bus Dev & Spec SalesForm 4 sale11,796$760k19.8%Plan not statedSEC
May 16, 2018Marshbanks TracyDirectorForm 4 sale38,236$2.4M9.9%Plan not statedSEC
May 10, 2018Marshbanks TracyDirectorForm 4 sale62,431$3.9M13.9%Plan not statedSEC
Apr 18, 2018Marshbanks TracyDirectorForm 4 sale33,200$2.1M6.9%Plan not statedSEC
Mar 19, 2018Raynor DanielDirectorForm 4 sale7,215$439k2.4%Plan not statedSEC
Mar 14, 2018Marshbanks TracyDirectorForm 4 sale1,912$121k0.4%Plan not statedSEC
Mar 14, 2018Przybyl ArthurPresident and CEOForm 4 sale40,000$2.5M17.7%Plan not statedSEC
Mar 14, 2018Raynor DanielDirectorForm 4 sale27,964$1.7M8.6%Plan not statedSEC
Mar 12, 2018Marshbanks TracyDirectorForm 4 sale64,221$4M11.7%Plan not statedSEC
Mar 5, 2018Marken James G.SVP Ops & Prod DevForm 4 sale4,177$259k6.0%Plan not statedSEC
Mar 1, 2018Schrepfer Robert WSVP - New Bus Dev & Spec SalesForm 4 sale28,652$1.8M68.9%UnusualSEC
Mar 1, 2018Przybyl ArthurPresident and CEOForm 4 sale23,986$1.5M10.3%Plan not statedSEC
Aug 22, 2016Przybyl ArthurPresident and CEOForm 4 sale37,455$2.5M16.3%Plan not statedSEC
Aug 8, 2016Schrepfer Robert WVP Bus Dev & Con MfgForm 4 sale12,500$838k41.9%UnusualSEC
Dec 18, 2015Marken James G.Vice President, OperationsForm 4 sale3,500$151k7.1%Plan not statedSEC
Mar 19, 2015Marken James G.Vice President, OperationsForm 4 sale15,000$998k32.2%UnusualSEC
Mar 12, 2015Marshbanks TracyDirectorForm 4 sale210,000$13.2M97.3%UnusualSEC
Mar 12, 2015Arnold Charlotte C.Vice President and CFOForm 4 sale45,000$2.8M67.8%UnusualSEC
Mar 12, 2015Przybyl ArthurPresident and CEOForm 4 sale75,000$4.7M39.6%UnusualSEC
Mar 12, 2015Meridian Venture Partners II LP10% ownerForm 4 sale300,000$18.9M11.3%Plan not statedSEC
Mar 12, 2015Raynor DanielDirectorForm 4 sale200,000$12.6M38.2%UnusualSEC
Jun 18, 2014Marken James G.Vice President, OperationsForm 4 sale5,000$171k9.7%Plan not statedSEC
May 8, 2014Marshbanks TracyDirectorForm 4 sale1,381$41k6.0%Plan not statedSEC
Mar 21, 2014Marshbanks TracyDirectorForm 4 sale21,767$684k72.9%UnusualSEC
Mar 20, 2014Brown Robert E. JRDirectorForm 4 sale20,922$672k0.8%Plan not statedSEC
Mar 19, 2014Marshbanks TracyDirectorForm 4 sale25,358$854k75.2%UnusualSEC
Mar 18, 2014Meridian Venture Partners II GP, L.P.10% ownerForm 4 sale60,540$2.1M2.2%Plan not statedSEC
Mar 14, 2014Raynor DanielDirectorForm 4 sale12,347$418k2.3%Plan not statedSEC
Mar 13, 2014Meridian Venture Partners II LP10% ownerForm 4 sale87,723$2.8M0.5%Plan not statedSEC
Mar 12, 2014Raynor DanielDirectorForm 4 sale21,111$715k0.6%Plan not statedSEC
May 7, 2007Holubow FredDirectorForm 4 sale7,500$51k10.9%Plan not statedSEC